AbelZeta to Present at the Annual J.P. Morgan Healthcare Conference

ROCKVILLE, MD, December 27, 2023 - AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on discovery and development of innovative and proprietary cell-based therapeutic products, today announced that Tony (Bizuo) Liu, Chairman and CEO, will present an update on the Company at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024.

Live Presentation:January 10, 2024
Time:8:00-8:25am PT
Location:Mission Bay (32nd Floor) The Westin, San Francisco